Aspirin May Reduce The Risk Of Colon Cancer

Low dose ‘baby aspirin’ may help certain individuals

Researchers at Cedar-Sinai have reported that long-term, regular use of “baby” aspirin – a low dose of 81 milligrams – taken at least 15 times a month, may reduce the risk of death from colorectal cancer by limiting the spread of cancerous tumors pre-diagnosis. Additionally, the National Cancer Institute reports that research has shown regular baby aspirin use could prevent nearly 11% of colorectal cancers diagnosed in the United States.

“These studies, as well as others, do seem to suggest that aspirin and similar anti-inflammatory drugs help reduce the risk of colorectal cancer in certain individuals,” says Angela McGee, MD, a board-certified Gastroenterology specialist at Kelsey-Seybold.

However, she cautions aspirin should never be used as a substitute for regular screening tests. “Additionally,” adds Dr. McGee, “aspirin therapy has side effects and drug interactions to consider, so no one should begin this therapy without talking to their personal physician first.”

“Additionally,” adds Dr. McGee, “aspirin therapy has side effects and drug interactions to consider, so no one should begin this therapy without talking to their personal physician first.”

Colorectal cancer is a leading cause of cancer deaths in the United States. A good percentage of those deaths could be avoided by regular screening tests to detect and remove polyps before they turn into cancer.

Regular screening is recommended for all Americans 50 years of age and older, and earlier if family members have a history of colorectal disease or cancer.